Leonette Olivia Kemp is a pharmacist who is specialized in Oncology in Miami, Florida. Patients can reach her at 8900 N Kendall Dr, Miami or contact her on 786-594-8583. Active license number of Leonette Olivia Kemp is PS-59176 for Oncology in Florida. Leonette Olivia Kemp is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Leonette Olivia Kemp speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Leonette Olivia Kemp
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
8900 N Kendall Dr, Miami, Florida, 33176-2118
Phone:
786-594-8583
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Leonette Olivia Kemp are as mentioned below.
NPI Number:
1700414679
NPI Enumeration Date:
27 Mar, 2020
NPI Last Update On:
27 Mar, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Leonette Olivia Kemp are as mentioned below.
Specialization
License Number
State
Status
Oncology
PS-59176
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
16560 Sw 137th Ave Apt 1422, Miami, Florida
Zip:
33177-2363
Phone Number:
901-413-8885
Fax Number:
--
Patients can reach Leonette Olivia Kemp at 8900 N Kendall Dr, Miami, Florida or can call on phone at 786-594-8583.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.